The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug of Abuse (DOA) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Drug of Abuse (DOA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug of Abuse (DOA) Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Drug of Abuse (DOA) Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Urine segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Drug of Abuse (DOA) Testing include Siemens, Merck, Roche, Thermo Fisher Scientific, and Bio-Rad, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug of Abuse (DOA) Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Urine
Saliva
Hair
Others
Market segment by Application, can be divided into
Hospitals
Laboratories
Workplace
At-Home
Others
Market segment by players, this report covers
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Drug of Abuse (DOA) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Drug of Abuse (DOA) Testing, with revenue, gross margin and global market share of Drug of Abuse (DOA) Testing from 2019 to 2022.
Chapter 3, the Drug of Abuse (DOA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Drug of Abuse (DOA) Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Drug of Abuse (DOA) Testing research findings and conclusion, appendix and data source.
Geographical Area
Global
The Drug of Abuse (DOA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug of Abuse (DOA) Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Drug of Abuse (DOA) Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Urine segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Drug of Abuse (DOA) Testing include Siemens, Merck, Roche, Thermo Fisher Scientific, and Bio-Rad, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug of Abuse (DOA) Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Urine
Saliva
Hair
Others
Market segment by Application, can be divided into
Hospitals
Laboratories
Workplace
At-Home
Others
Market segment by players, this report covers
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Drug of Abuse (DOA) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Drug of Abuse (DOA) Testing, with revenue, gross margin and global market share of Drug of Abuse (DOA) Testing from 2019 to 2022.
Chapter 3, the Drug of Abuse (DOA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Drug of Abuse (DOA) Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Drug of Abuse (DOA) Testing research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Drug of Abuse (DOA) Testing
1.2 Classification of Drug of Abuse (DOA) Testing by Type
1.2.1 Overview: Global Drug of Abuse (DOA) Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Type in 2021
1.2.3 Urine
1.2.4 Saliva
1.2.5 Hair
1.2.6 Others
1.3 Global Drug of Abuse (DOA) Testing Market by Application
1.3.1 Overview: Global Drug of Abuse (DOA) Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.3.6 Others
1.4 Global Drug of Abuse (DOA) Testing Market Size & Forecast
1.5 Global Drug of Abuse (DOA) Testing Market Size and Forecast by Region
1.5.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Drug of Abuse (DOA) Testing Market Size by Region, (2017-2022)
1.5.3 North America Drug of Abuse (DOA) Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Drug of Abuse (DOA) Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Drug of Abuse (DOA) Testing Market Size and Prospect (2017-2028)
1.5.6 South America Drug of Abuse (DOA) Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Drug of Abuse (DOA) Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug of Abuse (DOA) Testing Market Drivers
1.6.2 Drug of Abuse (DOA) Testing Market Restraints
1.6.3 Drug of Abuse (DOA) Testing Trends Analysis
2 Company Profiles
2.1 Siemens
2.1.1 Siemens Details
2.1.2 Siemens Major Business
2.1.3 Siemens Drug of Abuse (DOA) Testing Product and Solutions
2.1.4 Siemens Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Siemens Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Drug of Abuse (DOA) Testing Product and Solutions
2.2.4 Merck Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Drug of Abuse (DOA) Testing Product and Solutions
2.3.4 Roche Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Roche Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business
2.5.3 Bio-Rad Drug of Abuse (DOA) Testing Product and Solutions
2.5.4 Bio-Rad Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Bio-Rad Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Drug of Abuse (DOA) Testing Product and Solutions
2.6.4 Abbott Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business
2.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Product and Solutions
2.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Quest Diagnostics Recent Developments and Future Plans
2.8 Psychemedics
2.8.1 Psychemedics Details
2.8.2 Psychemedics Major Business
2.8.3 Psychemedics Drug of Abuse (DOA) Testing Product and Solutions
2.8.4 Psychemedics Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Psychemedics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drug of Abuse (DOA) Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Drug of Abuse (DOA) Testing Players Market Share in 2021
3.2.2 Top 10 Drug of Abuse (DOA) Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Drug of Abuse (DOA) Testing Players Head Office, Products and Services Provided
3.4 Drug of Abuse (DOA) Testing Mergers & Acquisitions
3.5 Drug of Abuse (DOA) Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Drug of Abuse (DOA) Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Drug of Abuse (DOA) Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Drug of Abuse (DOA) Testing Revenue Market Share by Application (2017-2022)
5.2 Global Drug of Abuse (DOA) Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Drug of Abuse (DOA) Testing Revenue by Type (2017-2028)
6.2 North America Drug of Abuse (DOA) Testing Revenue by Application (2017-2028)
6.3 North America Drug of Abuse (DOA) Testing Market Size by Country
6.3.1 North America Drug of Abuse (DOA) Testing Revenue by Country (2017-2028)
6.3.2 United States Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Drug of Abuse (DOA) Testing Revenue by Type (2017-2028)
7.2 Europe Drug of Abuse (DOA) Testing Revenue by Application (2017-2028)
7.3 Europe Drug of Abuse (DOA) Testing Market Size by Country
7.3.1 Europe Drug of Abuse (DOA) Testing Revenue by Country (2017-2028)
7.3.2 Germany Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
7.3.3 France Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region
8.3.1 Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Region (2017-2028)
8.3.2 China Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
8.3.5 India Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Drug of Abuse (DOA) Testing Revenue by Type (2017-2028)
9.2 South America Drug of Abuse (DOA) Testing Revenue by Application (2017-2028)
9.3 South America Drug of Abuse (DOA) Testing Market Size by Country
9.3.1 South America Drug of Abuse (DOA) Testing Revenue by Country (2017-2028)
9.3.2 Brazil Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country
10.3.1 Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Country (2017-2028)
10.3.2 Turkey Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Drug of Abuse (DOA) Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Drug of Abuse (DOA) Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Drug of Abuse (DOA) Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Drug of Abuse (DOA) Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Drug of Abuse (DOA) Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Drug of Abuse (DOA) Testing Revenue Market Share by Region (2023-2028)
Table 6. Siemens Corporate Information, Head Office, and Major Competitors
Table 7. Siemens Major Business
Table 8. Siemens Drug of Abuse (DOA) Testing Product and Solutions
Table 9. Siemens Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Drug of Abuse (DOA) Testing Product and Solutions
Table 13. Merck Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Roche Corporate Information, Head Office, and Major Competitors
Table 15. Roche Major Business
Table 16. Roche Drug of Abuse (DOA) Testing Product and Solutions
Table 17. Roche Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product and Solutions
Table 21. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 23. Bio-Rad Major Business
Table 24. Bio-Rad Drug of Abuse (DOA) Testing Product and Solutions
Table 25. Bio-Rad Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Abbott Corporate Information, Head Office, and Major Competitors
Table 27. Abbott Major Business
Table 28. Abbott Drug of Abuse (DOA) Testing Product and Solutions
Table 29. Abbott Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. Quest Diagnostics Major Business
Table 32. Quest Diagnostics Drug of Abuse (DOA) Testing Product and Solutions
Table 33. Quest Diagnostics Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Psychemedics Corporate Information, Head Office, and Major Competitors
Table 35. Psychemedics Major Business
Table 36. Psychemedics Drug of Abuse (DOA) Testing Product and Solutions
Table 37. Psychemedics Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Drug of Abuse (DOA) Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Drug of Abuse (DOA) Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Drug of Abuse (DOA) Testing Players Head Office, Products and Services Provided
Table 42. Drug of Abuse (DOA) Testing Mergers & Acquisitions in the Past Five Years
Table 43. Drug of Abuse (DOA) Testing New Entrants and Expansion Plans
Table 44. Global Drug of Abuse (DOA) Testing Revenue (USD Million) by Type (2017-2022)
Table 45. Global Drug of Abuse (DOA) Testing Revenue Share by Type (2017-2022)
Table 46. Global Drug of Abuse (DOA) Testing Revenue Forecast by Type (2023-2028)
Table 47. Global Drug of Abuse (DOA) Testing Revenue by Application (2017-2022)
Table 48. Global Drug of Abuse (DOA) Testing Revenue Forecast by Application (2023-2028)
Table 49. North America Drug of Abuse (DOA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 50. North America Drug of Abuse (DOA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 51. North America Drug of Abuse (DOA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Drug of Abuse (DOA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Drug of Abuse (DOA) Testing Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Drug of Abuse (DOA) Testing Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Drug of Abuse (DOA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 56. Europe Drug of Abuse (DOA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 57. Europe Drug of Abuse (DOA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Drug of Abuse (DOA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Drug of Abuse (DOA) Testing Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Drug of Abuse (DOA) Testing Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 62. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 63. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Drug of Abuse (DOA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 68. South America Drug of Abuse (DOA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 69. South America Drug of Abuse (DOA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Drug of Abuse (DOA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Drug of Abuse (DOA) Testing Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Drug of Abuse (DOA) Testing Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 74. Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 75. Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Drug of Abuse (DOA) Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Drug of Abuse (DOA) Testing Picture
Figure 2. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type in 2021
Figure 3. Urine
Figure 4. Saliva
Figure 5. Hair
Figure 6. Others
Figure 7. Drug of Abuse (DOA) Testing Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Laboratories Picture
Figure 10. Workplace Picture
Figure 11. At-Home Picture
Figure 12. Others Picture
Figure 13. Global Drug of Abuse (DOA) Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Drug of Abuse (DOA) Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Drug of Abuse (DOA) Testing Revenue Market Share by Region (2017-2028)
Figure 16. Global Drug of Abuse (DOA) Testing Revenue Market Share by Region in 2021
Figure 17. North America Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Drug of Abuse (DOA) Testing Market Drivers
Figure 23. Drug of Abuse (DOA) Testing Market Restraints
Figure 24. Drug of Abuse (DOA) Testing Market Trends
Figure 25. Siemens Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 29. Bio-Rad Recent Developments and Future Plans
Figure 30. Abbott Recent Developments and Future Plans
Figure 31. Quest Diagnostics Recent Developments and Future Plans
Figure 32. Psychemedics Recent Developments and Future Plans
Figure 33. Global Drug of Abuse (DOA) Testing Revenue Share by Players in 2021
Figure 34. Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Drug of Abuse (DOA) Testing Revenue Market Share in 2021
Figure 36. Global Top 10 Players Drug of Abuse (DOA) Testing Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Drug of Abuse (DOA) Testing Revenue Share by Type in 2021
Figure 39. Global Drug of Abuse (DOA) Testing Market Share Forecast by Type (2023-2028)
Figure 40. Global Drug of Abuse (DOA) Testing Revenue Share by Application in 2021
Figure 41. Global Drug of Abuse (DOA) Testing Market Share Forecast by Application (2023-2028)
Figure 42. North America Drug of Abuse (DOA) Testing Sales Market Share by Type (2017-2028)
Figure 43. North America Drug of Abuse (DOA) Testing Sales Market Share by Application (2017-2028)
Figure 44. North America Drug of Abuse (DOA) Testing Revenue Market Share by Country (2017-2028)
Figure 45. United States Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Drug of Abuse (DOA) Testing Sales Market Share by Type (2017-2028)
Figure 49. Europe Drug of Abuse (DOA) Testing Sales Market Share by Application (2017-2028)
Figure 50. Europe Drug of Abuse (DOA) Testing Revenue Market Share by Country (2017-2028)
Figure 51. Germany Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Drug of Abuse (DOA) Testing Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Drug of Abuse (DOA) Testing Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Drug of Abuse (DOA) Testing Revenue Market Share by Region (2017-2028)
Figure 59. China Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Drug of Abuse (DOA) Testing Sales Market Share by Type (2017-2028)
Figure 66. South America Drug of Abuse (DOA) Testing Sales Market Share by Application (2017-2028)
Figure 67. South America Drug of Abuse (DOA) Testing Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Drug of Abuse (DOA) Testing Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Drug of Abuse (DOA) Testing Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Drug of Abuse (DOA) Testing Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Drug of Abuse (DOA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
